In human adult T-cell-leukemia (ATL) cells, studies have demonstrated that APCCDC20 is a physiological E3 ligase that promotes the ubiquitination and destruction of the tumor suppressor, Bim, thus conferring resistance of cancer cells to chemoradiation. Here, BCL2L11 is linked to neoplasm.